CDRO Q4 2025 Earnings Narrowing Losses but EPS Misses Estimates Sharply CDP Q1 2026 Earnings Narrowly Beats EPS Estimates Amid Modest Stock Decline NCNA Q3 2024 Earnings Narrowed Loss Beats Expectations Myriad Genetics Q1 2026 Earnings EPS Miss Highlights Continued Operational Challenges PYPD Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances CPF Q1 2026 Earnings EPS Beats Estimates by 44 Amid Solid Operating Performance